The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma

Laryngoscope

Volumn 118, Issue 7, 2008, Pages 1191-1194

  Gourin, Christine G ^a,b   Conger, Bryant T ^a   Porubsky, Edward S ^a   Sheils, W Chris ^a   Bilodeau, Paul A ^a   Coleman, Teresa A ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cervical nodes; Extracapsular spread; Head and neck neoplasms; Squamous cell cancer; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK CARCINOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; LYMPH NODE; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; PERINEURIUM; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; ADJUVANT THERAPY; FOLLOW UP; HEAD AND NECK TUMOR; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT;

EID: 47149092274     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e31816e2eb7     Document Type: Article

References (21)

1. Shah JP. Patterns of cervical lymph node metastasis from squamous carcinoma of the upper aerodigestive tract. Am J Surg 1990;160:405-409.
2. Pittman KT, Johnson JT, Myers EN. Effectiveness of selective neck dissection for management of the clinically negative neck. Arch Otolaryngol Head Neck Surg 1997;123:917-922.
3. Barrera JE, Miller ME, Said S, et al. Detection of occult cervical micrometastases in patients with head and neck squamous cell cancer. Laryngoscope 2003;113:892-896.
4. Duvvuri U, Simental AA Jr, D'Angelo G, et al. Elective neck dissection and survival in patients with squamous cell carcinoma of the oral cavity and oropharynx. Laryngoscope 2004;114:2228-2234.
5. Alvi A, Johnson JT. Extracapsular spread in the clinically negative neck (NO) : implications and outcome. Otolaryngol Head Neck Surg 1996;114:65-70.
6. Oosterkamp S, de Jong JMA, Van Den Ende PL, et al. Predictive value of lymph node metastases and extracapsular extension for the risk of distant metastases in laryngeal carcinoma. Laryngoscope 2006;116:2067-2070.
7. Ferlito A, Rinaldo A, Silver CE, et al. Elective and therapeutic neck dissection. Oral Oncol 2006;42:13-24.
8. Gourin CG. Is selective neck dissection adequate treatment for node-positive disease? Arch Otolaryngol Head Neck Surg 2004;130:1431-1434.
9. Jose J, Coatesworth AP, Johnston C, MacLennan K. Cervical node metastasis in squamous cell carcinoma of the upper aerodigestive tract: the significance of extracapsular spread and soft tissue deposits. Head Neck 2003;25:451-456.
10. Kowalski LP, Carvalho AL. Feasibility of supraomohyoid neck dissection in N1 and N2a oral cancer patients. Head Neck 2002;24:921-924.
11. Spiro RH, Morgan GJ, Strong EW, Shah JP. Supraomohyoid neck dissection. Am J Surg 1996;172:650-653.
12. Byers RM, Clayman GL, McGill D, et al. Selective neck dissections for squamous carcinoma of the upper aerodigestive tract: patterns of regional failure. Head Neck 1999;21: 499-505.
13. Ambrosch P, Kron M, Pradier O, Steiner W. Efficacy of selective neck dissection: a review of 503 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Head Neck Surg 2001;124:180-187.
14. Brazilian Head Neck Cancer Study Group. Results of a prospective trial on elective modified radical classical versus supraomohyoid neck dissection in the management of oral squamous carcinoma. Am J Surg 1998;176:422-427.
15. Traynor SJ, Cohen JI, Gray J, Andersen PE, Everts EC. Selective neck dissection in management of the node-positive neck. Arch Otolaryngol Head Neck Surg 2002;128:1180-1184.
16. Hosal AS, Carrau RL, Johnson JT, Myers EN. Selective neck dissection in the management of the clinically nodenegative neck. Laryngoscope 2000;110:2037-2040.
17. Chepeha DB, Hoff PT, Taylor RJ, et al. Selective neck dissection for the treatment of neck metastasis from squamous cell carcinoma of the head and neck. Laryngoscope 2002;112:434-438.
18. Kocatürk S, Yilmazer D, Önal B, et al. Do micrometastases detected with cytokeratin immunoperoxidase reactivity affect the treatment approach to neck in supraglottic cancers? Otolaryngol Head Neck Surg 2003;128:407-411.
19. Muzaffar K. Therapeutic selective neck dissection: a 25-year review. Laryngoscope 2003;113:1460-1465.
20. Johnson JT, Wagner RL, Myers EN. A long-term assessment of adjuvant chemotherapy on the outcome of patients with extracapsular spread of cervical metastases from squamous cell carcinoma of the head and neck. Cancer 1996;77:181-185.
21. Cooper JS, Patak TF, Forastiere AA, et al. Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-1944.